HopeStage
Back to all studies
RecruitingNCT07543328

Light-based brain stimulation for physical symptoms of treatment-resistant depression

About this titleRead the official source — NCT07543328
Device studyAges 18–65Taiwan
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
TaipeiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 6, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
40
Sponsor
Taipei Veterans General Hospital, Taiwan
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
Taiwan
Age range
From 18 Years to 65 Years
Official registry ID
NCT07543328
Official title
Show the full official title

The Clinical Efficacy of Prefrontal Transcranial Photobiomodulation (tPBM) in Patients With Treatment-Resistant Major Depressive Disorder: A Subgroup Analysis Focusing on Somatic Symptoms

Recruitment & locations

Currently recruiting

Taipei

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Taipei Veterans General Hospital, Taiwan, a hospital or academic medical center.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies